These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The excretion of mepacrine in the faeces. MAEGRAITH BG; BROWN GM Ann Trop Med Parasitol; 1946 Dec; 40(3-4):372-9. PubMed ID: 20289239 [No Abstract] [Full Text] [Related]
43. An epidemic of gastro-enteritis in infants, with special reference to treatment. STABLE G; PHILPOTT IG Med J Aust; 1948 Jul; 2(3):63-9. PubMed ID: 18873934 [No Abstract] [Full Text] [Related]
44. Eosinophilic gastroenteritis: A state-of-the-art review. Zhang M; Li Y J Gastroenterol Hepatol; 2017 Jan; 32(1):64-72. PubMed ID: 27253425 [TBL] [Abstract][Full Text] [Related]
45. Mepacrine and mental derangement. SUBEDAR SA Indian Med J; 1947 Nov; 41(11):238. PubMed ID: 18904195 [No Abstract] [Full Text] [Related]
46. The effect of various substances, including food, on the absorption of orally administered mepacrine hydrochloride. MAEGRAITH BG; BROWN GM Ann Trop Med Parasitol; 1946 Dec; 40(3-4):482-92. PubMed ID: 20289244 [No Abstract] [Full Text] [Related]
47. Blood and plasma concentrations of mepacrine in subjects taking suppressive and therapeutic dosages. MAEGRAITH BG; BROWN GM Ann Trop Med Parasitol; 1946 Dec; 40(3-4):472-81. PubMed ID: 20289243 [No Abstract] [Full Text] [Related]
48. Mepacrine inhibits matrix metalloproteinases-1 (MMP-1) and MMP-9 activation in human fibroblast-like synoviocytes. Stuhlmeier KM J Rheumatol; 2003 Nov; 30(11):2330-7. PubMed ID: 14677173 [TBL] [Abstract][Full Text] [Related]
49. Gastroenteritis in man due to a filtrable agent. GORDON I; INGRAHAM HS N Y State J Med; 1949 Aug; 49(16):1918-20. PubMed ID: 18136344 [No Abstract] [Full Text] [Related]
50. Field methods for estimating mepacrine in urine, blood and plasma. KING EJ; GILCHRIST Trans R Soc Trop Med Hyg; 1945 Sep; 39(1):10-2. PubMed ID: 20293976 [No Abstract] [Full Text] [Related]
51. A resolution of mepacrine [2-chloro-5-(sigma-diethylamino-alpha-methylbutyl) amino-7-methoxyacridine]. BROWN BR; HAMMICK DL J Chem Soc; 1948 Jan; ():99. PubMed ID: 18903734 [No Abstract] [Full Text] [Related]
52. A resolution of mepacrine [2-chloro-5-(delta-diethylamino-alpha-methylbutyl) amino-7-methoxyacridine]. BROWN BR; HAMMICK DL J Chem Soc; 1948 Feb; ():99. PubMed ID: 18906361 [No Abstract] [Full Text] [Related]
53. Mepacrine, a phospholipase inhibitor. A potential tool for modifying myocardial reperfusion injury. Otani H; Engelman RM; Breyer RH; Rousou JA; Lemeshow S; Das DK J Thorac Cardiovasc Surg; 1986 Aug; 92(2):247-54. PubMed ID: 3736082 [TBL] [Abstract][Full Text] [Related]
55. Mepacrine blockade of arachidonate-induced washed platelet aggregation: relationship to mepacrine inhibition of platelet cyclooxygenase. Raz A Thromb Haemost; 1983 Dec; 50(4):784-6. PubMed ID: 6420923 [TBL] [Abstract][Full Text] [Related]
56. Distribution of mepacrine in blood. MAEGRAITH BG; BROWN GM Ann Trop Med Parasitol; 1946 Jul; 40():181-9. PubMed ID: 20997902 [No Abstract] [Full Text] [Related]
57. Sexual disorder in 'mepacrine psychoses'. KAPUR KB; DAS GUPTA PR Ind Med Gaz; 1950 Jan; 85(1):20-2. PubMed ID: 15412077 [No Abstract] [Full Text] [Related]
58. The effect of muscular exercise in a hot moist environment on the mepacrine concentrations of blood, plasma and urine. MAEGRAITH BG; BROWN GM Ann Trop Med Parasitol; 1946 Dec; 40(3-4):368-71. PubMed ID: 20289238 [No Abstract] [Full Text] [Related]
59. Mepacrine in animal tissues. MAEGRAITH BG; BROWN GM Ann Trop Med Parasitol; 1946 Jul; 40():173-80. PubMed ID: 20997901 [No Abstract] [Full Text] [Related]
60. The toxicity of mepacrine in man. FINDLAY GM Trop Dis Bull; 1947 Sep; 44(9):763-79. PubMed ID: 18906096 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]